ArticleCancer chemotherapy and pharmacology2026

BET inhibitor OPN-2853 in advanced solid tumors and lymphoma: results from the phase 1b PLX124-01 trial.

Michael S Gordon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.